Rezolute (NASDAQ:RZLT) Trading Up 12.5%

Rezolute (NASDAQ:RZLT)’s stock price was up 12.5% on Friday . The stock traded as high as $0.14 and last traded at $0.14, approximately 14,500 shares were traded during trading. A decline of 50% from the average daily volume of 28,864 shares. The stock had previously closed at $0.12.

Separately, JMP Securities started coverage on Rezolute in a report on Wednesday, October 9th. They set an “outperform” rating and a $0.55 price objective on the stock.

The firm’s fifty day moving average price is $0.14.

Rezolute (NASDAQ:RZLT) last released its quarterly earnings data on Thursday, November 14th. The company reported ($0.02) earnings per share for the quarter.

About Rezolute (NASDAQ:RZLT)

Rezolute, Inc, a clinical stage biopharmaceutical company, specializes in the development of drug therapies for the treatment of patients with metabolic and orphan diseases in the United States. Its products include RZ358, a human monoclonal antibody that is in Phase II clinical trial for the treatment of congenital hyperinsulinism, a devastating ultra-orphan pediatric disease; RZ402, a plasma kallikrein inhibitor, which is in late stage preclinical program for the treatment of diabetic macular edema; and RZ602, a product candidate that is in preclinical trial for the treatment of hereditary angioedema.

Featured Story: How can investors find ex-dividend dates?

Receive News & Ratings for Rezolute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rezolute and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit